Empiric antifungal therapy in the management of the febrile-granulocytopenic cancer patient.
D000380:Agranulocytosis / Q000150:complications*; D000666:Amphotericin B / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use*; D002228:Carbenicillin / Q000627:therapeutic use; D002512:Cephalothin / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005839:Gentamicins / Q000627:therapeutic use; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects; D007239:Infections / Q000150:complications; D009181:Mycoses / Q000150:complications* / Q000188:drug therapy; D009369:Neoplasms / Q000150:complications*
D000935:Antifungal Agents; D005839:Gentamicins; D000666:Amphotericin B; D002228:Carbenicillin; D002512:Cephalothin